0.57 USD
↘ 0.03 (5.68%)AT CLOSE (11:59 AM EDT)
MDxHealth SA Ordinary Shares
MDXHNASDAQ • USD
0.58
↗ 0.01 (1.61%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.58
↗ 0.01 (1.61%)
Market: CLOSED
Open?$0.61
High?$0.61
Low?$0.51
Prev. Close?$0.60
Volume?1.0M
Avg. Volume?N/A
VWAP?$0.57
Bid / Ask
Bid?$0.57 × 100
Ask?$0.58 × 100
Spread?$0.01
Midpoint?$0.57
Valuation & Ratios
Market Cap?29.1M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
MDXH is currently priced at $0.57. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Themes
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?-8.52Distress
Confidence?38%Very Low
Short InterestLow
Short Interest?910.3K
Days to Cover?1.0
Avg Daily Volume1.6M
Settlement Date2026-05-15